Oxford PharmaScience is a specialty pharmaceutical company developing advanced formulation technologies for the global pain-relief market.
Founded on research from the University of Oxford, the company has developed a proprietary Layered Double Hydroxide (LDH) platform that creates differentiated salt forms of established analgesics with enhanced performance characteristics.
Our Approach
• Clear regulatory pathway – leveraging established API safety profiles
• Faster onset of action – earlier Tmax than current formulations
• Improved patient and consumer experience – taste-masking and convenient formats
• Designed for gastric comfort – formulations optimised for reduced irritation potential
Rather than pursuing vertical integration, we partner with pharmaceutical companies who have the commercial capabilities to maximise market impact.
Current Focus
Oxford PharmaScience is actively partnering with leading companies to develop and commercialize next-generation analgesic products. Our platform technology offers multiple market applications, streamlined development timelines, flexible formulation options, and strong IP protection.
Partnership
For partnership inquiries: contact@pharmascience.co.uk